Nothing new in the presentation, almost word for word the same as the last one. They mentioned that numbers and projections will be out after earnings. The presentation is strong from a medical angle in explaining how the drugs work. Weak in the financial presentation in explaining based on projections how big this can be, makes me wonder if this intentional at this point. Strange that they have not updated any numbers since the two presentations, even keeping old news, not professional. Anyone know when earnings is released?
Anyway, for now SUPG looks like one of the best kept drug makers in the market. Sure we will see over $15 this year, patience.